Literature DB >> 21565674

How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids.

Sharon L H Ong1, Judith A Whitworth.   

Abstract

The exact mechanism by which glucocorticoid induces hypertension is unclear. Several mechanisms have been proposed, although there is evidence against the role of sodium and water retention as well as sympathetic nerve activation. This review highlights the role of nitric oxide-redox imbalance and their interactions with arachidonic acid metabolism in glucocorticoid-induced hypertension in humans and experimental animal models. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21565674     DOI： 10.1016/j.ecl.2011.01.010

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  15 in total

1.  The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.

Authors:  P M Williamson; S L H Ong; J A Whitworth; J J Kelly
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

2.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.

Authors:  Andrea Rebellato; Andrea Grillo; Francesca Dassie; Nicoletta Sonino; Pietro Maffei; Chiara Martini; Agostino Paoletta; Bruno Fabris; Renzo Carretta; Francesco Fallo
Journal:  Endocrine       Date:  2014-01-10       Impact factor: 3.633

Review 3.  Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.

Authors:  Laurence Fardet; Bruno Fève
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

4.  Coronary microvascular function in patients with Cushing's syndrome.

Authors:  Francesco Fallo; Giulia Famoso; Dario Capizzi; Nicoletta Sonino; Francesca Dassie; Pietro Maffei; Chiara Martini; Agostino Paoletta; Sabino Iliceto; Francesco Tona
Journal:  Endocrine       Date:  2012-08-01       Impact factor: 3.633

Review 5.  Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

6.  The Effect of Protocatechuic Acid on Blood Pressure and Oxidative Stress in Glucocorticoid-induced Hypertension in Rat.

Authors:  Leila Safaeian; Valiollah Hajhashemi; Shaghayegh Haghjoo Javanmard; Hamed Sanaye Naderi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  Antioxidant effects of bovine lactoferrin on dexamethasone-induced hypertension in rat.

Authors:  Leila Safaeian; Hadi Zabolian
Journal:  ISRN Pharmacol       Date:  2014-01-22

Review 8.  Association between hypertension and periodontitis: possible mechanisms.

Authors:  Xin-Fang Leong; Chun-Yi Ng; Baharin Badiah; Srijit Das
Journal:  ScientificWorldJournal       Date:  2014-01-08

Review 9.  Anti-hypertensive Herbs and their Mechanisms of Action: Part I.

Authors:  Sara S Al Disi; M Akhtar Anwar; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-01-19       Impact factor: 5.810

10.  Ethnopharmacological Survey on Treatment of Hypertension by Traditional Healers in Bukavu City, DR Congo.

Authors:  Félicien Mushagalusa Kasali; Christian Ahadi Irenge; Pacifique Murhula Hamuli; Patient Birindwa Mulashe; Delphin Murhula Katabana; Jean De Dieu Mangambu Mokoso; Pius Tshimankinda Mpiana; Justin Ntokamunda Kadima
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-09       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.